International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy-Reference-Cited by-同舟云学术

International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy

Published:2009-09-02 Issue:17 Volume:101 Page:1174-1181
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Cardoso Fatima¹,Bedard Philippe L.¹,Winer Eric P.¹,Pagani Olivia¹,Senkus-Konefka Elzbieta¹,Fallowfield Lesley J.¹,Kyriakides Stella¹,Costa Alberto¹,Cufer Tanja¹,Albain Kathy S.¹,

Affiliation:

1. Affiliations of authors: Department of Medical Oncology, Medical Oncology & Translational Research Unit, Jules Bordet Institute, Brussels, Belgium (FC, PLB); Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (EPW); Department of Medical Oncology, Oncology Institute of Southern Switzerland, Ospedale Italiano, Viganello, Lugano (OP); Switzerland

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/101/17/1174/17310480/djp235.pdf

Reference58 articles.

1. Recommendations proposal from the European School of Oncology (ESO)-MBC Task Force;Metastatic breast cancer;Breast,2007

2. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007;Goldhirsch;Ann Oncol,2007

3. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer;Harris;J Clin Oncol,2007

4. Second consensus on medical treatment of metastatic breast cancer;Beslija;Ann Oncol,2007

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synchronized Codelivery of Combination Chemotherapies Intratumorally Using a Lipidic Lyotropic Liquid Crystal System;ACS Applied Materials & Interfaces;2024-05-23

2. Breast Cancer;Geriatric Medicine;2024

3. Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear Benefits;Journal of Clinical Oncology;2023-12-20

4. Breast Cancer;Geriatric Medicine;2023-12-05

5. Peptide-Hydrogel Nanocomposites for Anti-Cancer Drug Delivery;Gels;2023-12-04